The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 6, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1038/s41419-018-0688-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
- (2018) Hsueh-Yun Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease
- (2015) A. Lloret et al. FREE RADICAL BIOLOGY AND MEDICINE
- Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells
- (2015) Nan Lin et al. MOLECULAR NEUROBIOLOGY
- The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
- (2015) Yanuar Alan Sulistio et al. MOLECULAR NEUROBIOLOGY
- Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation
- (2015) Yixuan Wang et al. NEUROBIOLOGY OF AGING
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease
- (2013) Chao-Wu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutics of Alzheimer's disease: Past, present and future
- (2013) R. Anand et al. NEUROPHARMACOLOGY
- Brain expression level and activity of HDAC6 protein in neurodegenerative dementia
- (2012) Saori Odagiri et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
- (2012) Nambirajan Govindarajan et al. EMBO Molecular Medicine
- Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation
- (2012) Casey Cook et al. HUMAN MOLECULAR GENETICS
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
- (2010) Brian R. Hoover et al. NEURON
- Novel insights for the treatment of Alzheimer's disease
- (2010) Alexander Kurz et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- GSK3: A possible link between beta amyloid peptide and tau protein
- (2009) Félix Hernández et al. EXPERIMENTAL NEUROLOGY
- Histone deacetylase 6 interacts with the microtubule-associated protein tau
- (2008) Huiping Ding et al. JOURNAL OF NEUROCHEMISTRY
- Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
- (2008) Y. Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- HDAC6: a key regulator of cytoskeleton, cell migration and cell–cell interactions
- (2008) Agustín Valenzuela-Fernández et al. TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now